However, it was reported that 18F-FDG PET/CT radiomic features have significant potential in predicting EGFR mutation subtypes in patients with lung adenocarcinoma, achieving a notable AUC of 0.87 for the combined model of predicting EGFR mutation positivity (37). This evidence concerns the gene EGFR and lung adenocarcinoma.